Role of a gene in breast cancer
Part of Cancer, Skin clinical trials.
This study looks at a specific gene (PCGEM1) in breast cancer tissue to see if it can help predict how the disease may progress. It may lead to better tailored treatments for people with breast cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have just been diagnosed with breast cancer (any stage) confirmed by biopsy
- You do not have any long-term health conditions (like diabetes, high blood pressure, or heart disease)
- You have never had cancer before
- Your cancer has not spread to distant organs at diagnosis
- You have not received chemotherapy or radiation therapy yet
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how genomic tests (which analyze your tumor's genes) are used in routine care for early-stage breast cancer that is hormone-sensitive. It may help doctors understand who really needs chemotherapy in addition to hormone therapy.
This study links breast tumor test results from MammaPrint and optional BluePrint (and full genetic data) with real-world clinical information to understand which new gene activity patterns matter. It may help future patients by improving how doctors use these tests to guide care.
This study looks at the genetic changes in breast cancer patients, especially those with a family history or early onset. It may help doctors understand which genes are common in Chinese breast cancer patients and guide future treatment options.
This study looks at the genes in your cancer to find a treatment that might work better for you. It tests your tumor sample to match you with a drug that targets your cancer's specific weaknesses.
This study looks at how genes, the cancer environment, and your immune system interact to develop treatments that work better for people with breast cancer. It may help researchers learn why some treatments work for certain people and not others.
This study tests a tool to help people newly diagnosed with early-stage breast cancer better understand their gene test results. It is for patients who haven't yet decided about chemotherapy and want to learn more about their options.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.